Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Skymark Research Initiates Independent Research Coverage On Vion Pharmaceuticals, Inc.
Thursday, September 10, 2009 8:31 AM
Email Article
Bookmark:
Font Size
Print Article
Sep. 10, 2009 (GlobeNewswire) -- Dylan Boyle
202-657-6249
info@skymarkresearch.com
(Source: iStockAnalyst )
Bookmark:
Email Article
Print Article
Related Stories
Subscribe to
Email Alerts
Fed Balance Sheet Declines By $15 Billion After Improbable Reduction In MBS, Excess Reserves, Monetary Base Hit Record
China Will Continue To Drive The Global Economic Recovery In 2010
Interesting Stat: How Much Private Sector GDP Is From Construction And Real Estate?
Credit Market Overview: Dec 3, 2009
Grab Some Northern Exposure With EWC
Rate this Commentary
Comments
(0)
No Comments
Post Comment
Name:
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
Related Press Releases
Vion Pharmaceuticals Reports 2009 Second Quarter And Six-Month Results
Vion Pharmaceuticals Announces Oncologic Drugs Advisory Committee Meeting for Onrigin(TM)
Vion Pharmaceuticals Presents Data on Onrigin(TM) Elderly AML Trials at the ASCO(R) Annual Meeting
Vion Pharmaceuticals to Present Data on Onrigin(TM)at the ASCO(R) Annual Meeting
Vion Pharmaceuticals Reports 2009 First Quarter Results
Advertisement
Popular Articles
Can U.S. Bank Stocks Double Again In 2010?
By:
Money Morning
AIG Going Down And Down
By:
iStockAnalyst
Turnaround Expert: 8 Stocks Below 1999 Highs
By:
TheStockAdvisors.com
7 Dividend Stocks To Take The Emotion Out Of Investing
By:
Dividends4Life
You Can Earn 10% From The Safest Company In America : BRK.A, BRK.B
By:
Tom Dyson
Advertisement
Partner Center
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
